Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
- PMID: 35717380
- PMCID: PMC9206260
- DOI: 10.1186/s13020-022-00633-4
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
Abstract
Inflammatory bowel disease (IBD) is a chronic recurrent inflammatory disease of the intestine, including Crohn's disease (CD) and ulcerative colitis (UC), whose etiology and pathogenesis have not been fully understood. Due to its prolonged course and chronic recurrence, IBD imposes a heavy economic burden and psychological stress on patients. Traditional Chinese Herbal Medicine has unique advantages in IBD treatment because of its symptomatic treatment. However, the advantages of the Chinese Herbal Medicine Formula (CHMF) have rarely been discussed. In recent years, many scholars have conducted fundamental studies on CHMF to delay IBD from different perspectives and found that CHMF may help maintain intestinal integrity, reduce inflammation, and decrease oxidative stress, thus playing a positive role in the treatment of IBD. Therefore, this review focuses on the mechanisms associated with CHMF in IBD treatment. CHMF has apparent advantages. In addition to the exact composition and controlled quality of modern drugs, it also has multi-component and multi-target synergistic effects. CHMF has good prospects in the treatment of IBD, but its multi-agent composition and wide range of targets exacerbate the difficulty of studying its treatment of IBD. Future research on CHMF-related mechanisms is needed to achieve better efficacy.
Keywords: Autophagy; Chinese herbal medicine formula; Immunity; Inflammatory bowel disease; Intestinal mucosal barrier; Oxidative stress.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease.Phytomedicine. 2021 Nov;92:153709. doi: 10.1016/j.phymed.2021.153709. Epub 2021 Sep 6. Phytomedicine. 2021. PMID: 34560518 Review.
-
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.Molecules. 2024 Jan 12;29(2):379. doi: 10.3390/molecules29020379. Molecules. 2024. PMID: 38257292 Free PMC article. Review.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294387 Free PMC article.
-
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28. J Ethnopharmacol. 2020. PMID: 31891799 Review.
-
Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.Gastroenterology. 2017 Sep;153(3):723-731.e1. doi: 10.1053/j.gastro.2017.05.056. Epub 2017 Jun 8. Gastroenterology. 2017. PMID: 28601482
Cited by
-
Effects of Designed Herbal Formula on Growth Performance, Blood Indices, Organ Traits, and Cecum Microbiology in Broilers.Vet Sci. 2024 Feb 29;11(3):107. doi: 10.3390/vetsci11030107. Vet Sci. 2024. PMID: 38535841 Free PMC article.
-
Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis.Drug Des Devel Ther. 2023 May 23;17:1531-1546. doi: 10.2147/DDDT.S407339. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37249930 Free PMC article.
-
A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis.Chin Med. 2023 Aug 11;18(1):98. doi: 10.1186/s13020-023-00801-0. Chin Med. 2023. PMID: 37568235 Free PMC article.
-
Quality of reporting of integrative Chinese and Western medicine intervention in randomized controlled trials of ulcerative colitis: a review.Syst Rev. 2023 Dec 8;12(1):228. doi: 10.1186/s13643-023-02402-2. Syst Rev. 2023. PMID: 38062492 Free PMC article. Review.
-
Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease.World J Gastroenterol. 2023 Jul 21;29(27):4252-4270. doi: 10.3748/wjg.v29.i27.4252. World J Gastroenterol. 2023. PMID: 37545642 Free PMC article. Review.
References
-
- Al-Mustanjid M, Mahmud SMH, Royel MRI, Rahman MH, Islam T, Rahman MR, et al. Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: a bioinformatics and systems biology approach. Genomics. 2020;112(5):3416–3426. doi: 10.1016/j.ygeno.2020.06.001. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources